Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,747,552
-$324,568 QoQ
Shares Held
114,101
+4.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#830
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2026CallValue
$28,080
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Old Port Advisors holds $21,158,060 across 12 Drug Manufacturers - General names. PFE ranks #3 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
69,539 | $3,645,234 | |
| 2 | NVS |
Novartis AG
|
21,266 | $3,332,807 | |
| 3 | PFE |
Pfizer Inc
This page
|
114,101 | $2,747,552 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
36,348 | $2,094,371 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
16,332 | $2,063,384 | |
| 6 | SNY |
Sanofi
|
48,080 | $2,051,092 | |
| 7 | LLY |
ELI LILLY & Co
|
1,253 | $1,502,885 | |
| 8 | JNJ |
Johnson & Johnson
|
5,683 | $1,443,311 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,747,552 | 114,101 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $3,072,120 | 109,406 | Shares | Sole | 2026-04-06 | |
| 2026-03-31 | $28,080 | 1,000 | Call | Sole | 2026-04-06 | |
| 2025-12-31 | $2,525,432 | 101,423 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $2,692,471 | 105,670 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $2,438,083 | 100,581 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,262,684 | 89,293 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,177,449 | 82,075 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $2,564,170 | 88,603 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,578,301 | 92,148 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,508,017 | 90,379 | Shares | Sole | 2024-06-26 | |
| 2023-12-31 | $2,354,331 | 81,776 | Shares | Sole | 2024-06-26 | |
| 2023-09-30 | $3,214,504 | 96,910 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $3,939,892 | 96,566 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $5,001,638 | 97,612 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $4,313,554 | 98,573 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $5,135,308 | 97,946 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $5,094,375 | 98,404 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $5,936,532 | 100,534 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $4,231,452 | 98,383 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $3,815,280 | 97,428 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $3,525,976 | 97,322 | Shares | Sole | 2021-04-08 | |
| 2020-12-31 | $3,575,024 | 97,121 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $3,529,912 | 96,183 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $3,051,828 | 93,328 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $2,927,836 | 89,701 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||